Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors
The study suggests that the use of adjuvant abemaciclib is not associated with an increased risk of postradiation reconstructive complications in patients undergoing implant-based reconstruction. Continued surveillance of complications associated with abemaciclib is warranted with a larger sample size.
Authors
- A. Leilani Fahey
- Catherine Loveland‐Jones
- Christine Kurian (ORCID: https://orcid.org/0000-0002-8295-6414)
- Badal Juneja (ORCID: https://orcid.org/0009-0002-4131-4383)
- Danny Markabawi
- Steven C. Bonawitz (ORCID: https://orcid.org/0000-0003-2575-2869)
- Hamail Iqbal (ORCID: https://orcid.org/0000-0003-3156-3845)
- Leah Steinmetz
- Stuti Ahlawat
- Anthony E. Dragun
- Sophia Chryssofos
Institutions
- Cooper Medical School of Rowan University (US)
- Palmetto Hematology Oncology (US)
- Cooper University Health Care (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/coc.0000000000001186
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00